Merit Medical Systems Long Term Debt 2010-2024 | MMSI

Merit Medical Systems long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Merit Medical Systems long term debt for the quarter ending September 30, 2024 was $0.751B, a 165.79% increase year-over-year.
  • Merit Medical Systems long term debt for 2023 was $0.823B, a 340.68% increase from 2022.
  • Merit Medical Systems long term debt for 2022 was $0.187B, a 20.32% decline from 2021.
  • Merit Medical Systems long term debt for 2021 was $0.234B, a 31.81% decline from 2020.
Merit Medical Systems Annual Long Term Debt
(Millions of US $)
2023 $823
2022 $187
2021 $234
2020 $344
2019 $432
2018 $373
2017 $259
2016 $314
2015 $198
2014 $214
2013 $239
2012 $228
2011 $31
2010 $82
2009 $
Merit Medical Systems Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $751
2024-06-30 $801
2024-03-31 $800
2023-12-31 $823
2023-09-30 $282
2023-06-30 $335
2023-03-31 $186
2022-12-31 $187
2022-09-30 $205
2022-06-30 $236
2022-03-31 $243
2021-12-31 $234
2021-09-30 $271
2021-06-30 $285
2021-03-31 $313
2020-12-31 $344
2020-09-30 $350
2020-06-30 $403
2020-03-31 $438
2019-12-31 $432
2019-09-30 $432
2019-06-30 $385
2019-03-31 $362
2018-12-31 $373
2018-09-30 $187
2018-06-30 $392
2018-03-31 $366
2017-12-31 $259
2017-09-30 $261
2017-06-30 $225
2017-03-31 $220
2016-12-31 $314
2016-09-30 $318
2016-06-30 $222
2016-03-31 $218
2015-12-31 $198
2015-09-30 $200
2015-06-30 $200
2015-03-31 $203
2014-12-31 $214
2014-09-30 $230
2014-06-30 $238
2014-03-31 $244
2013-12-31 $239
2013-09-30 $241
2013-06-30 $247
2013-03-31 $244
2012-12-31 $228
2012-09-30 $65
2012-06-30 $57
2012-03-31 $53
2011-12-31 $31
2011-09-30 $6
2011-06-30 $55
2011-03-31 $83
2010-12-31 $82
2010-09-30 $88
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.972B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.233B 19.03
Becton Dickinson (BDX) United States $69.388B 18.80
Cardinal Health (CAH) United States $27.972B 15.17
West Pharmaceutical Services (WST) United States $23.854B 48.72
Cooper (COO) United States $20.668B 29.42
Labcorp (LH) United States $19.603B 16.25
Align Technology (ALGN) United States $16.786B 32.12
Henry Schein (HSIC) United States $8.871B 16.63
DENTSPLY SIRONA (XRAY) United States $4.861B 13.03
CONMED (CNMD) United States $2.337B 19.50
Patterson (PDCO) United States $1.938B 10.23
STAAR Surgical (STAA) United States $1.521B 56.11
Lifevantage (LFVN) United States $0.175B 23.23
Pro-Dex (PDEX) United States $0.140B 27.95